Infectious complications associated with immunomodulating biologic agents.
about
Invasive fungal infections in pediatric patients treated with tumor necrosis alpha (TNF-α) inhibitorsATS Core Curriculum 2014: part I. Adult pulmonary medicine.Protothecosis in hematopoietic stem cell transplantation: case report and review of previous cases.Legionnaires' disease in transplant recipients: A 15-year retrospective study in a tertiary referral center.Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors.Urinary tuberculosis associated to adalimumab.Limbic encephalitis and related cortical syndromes.
P2860
Q29302324-9E42A02F-D214-40B5-A300-A93EA1D6DD40Q33786162-2A61575D-D024-4062-B302-66A76FFF21AFQ38209460-32142FF1-2B00-41DB-94F8-664C66967AB9Q38684548-8C0EDA56-B844-426D-9558-6C9E4C61978DQ39264020-53F90E79-CF0B-4CCC-B981-E1D9692AFBDEQ42058710-3E15D807-A7AE-43D2-A70B-170ABAF1E89EQ44187530-54DCEEB7-2738-4397-8F71-16EA660E8C56
P2860
Infectious complications associated with immunomodulating biologic agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Infectious complications associated with immunomodulating biologic agents.
@en
Infectious complications associated with immunomodulating biologic agents.
@nl
type
label
Infectious complications associated with immunomodulating biologic agents.
@en
Infectious complications associated with immunomodulating biologic agents.
@nl
prefLabel
Infectious complications associated with immunomodulating biologic agents.
@en
Infectious complications associated with immunomodulating biologic agents.
@nl
P50
P1476
Infectious complications associated with immunomodulating biologic agents
@en
P304
P356
10.1016/J.HOC.2010.11.009
P577
2011-02-01T00:00:00Z